Status:
UNKNOWN
Prebiotic Therapy to Improve Outcomes of Renal Transplant
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
The W. Garfield Weston Foundation
St. Joseph's Health Care London
Conditions:
Kidney Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
An investigator initiated pilot study: two arm, double blind, placebo controlled, randomized, group of approximately 60 patients undergoing a kidney transplant. Participants will be treated with human...
Detailed Description
Nearly three million people worldwide suffer from end stage renal disease (ESRD), which has debilitating consequences on the quality of life of patients There is a discrepancy between the availability...
Eligibility Criteria
Inclusion
- 18 years of age and over receiving a kidney transplant.
Exclusion
- Under 18 years of age
- Inability to give consent
- Usage of probiotics or other prebiotics.
- Have had carcinomas during the last 5 years
- Bowel surgery
- Crohn ́s disease and other conditions.
Key Trial Info
Start Date :
February 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04428190
Start Date
February 23 2022
End Date
December 15 2024
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre
London, Ontario, Canada, N6A 5A5